Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice
Peter J. Gough, … , Paul T. Wille, Elaine W. Raines
Peter J. Gough, … , Paul T. Wille, Elaine W. Raines
Published January 4, 2006
Citation Information: J Clin Invest. 2006;116(1):59-69. https://doi.org/10.1172/JCI25074.
View: Text | PDF
Research Article Cardiology

Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice

  • Text
  • PDF
Abstract

The majority of acute clinical manifestations of atherosclerosis are due to the physical rupture of advanced atherosclerotic plaques. It has been hypothesized that macrophages play a key role in inducing plaque rupture by secreting proteases that destroy the extracellular matrix that provides physical strength to the fibrous cap. Despite reports detailing the expression of multiple proteases by macrophages in rupture-prone regions, there is no direct proof that macrophage-mediated matrix degradation can induce plaque rupture. We aimed to test this hypothesis by retrovirally overexpressing the candidate enzyme MMP-9 in macrophages of advanced atherosclerotic lesions of apoE–/– mice. Despite a greater than 10-fold increase in the expression of MMP-9 by macrophages, there was only a minor increase in the incidence of plaque fissuring. Subsequent analysis revealed that macrophages secrete MMP-9 predominantly as a proform, and this form is unable to degrade the matrix component elastin. Expression of an autoactivating form of MMP-9 in macrophages in vitro greatly enhances elastin degradation and induces significant plaque disruption when overexpressed by macrophages in advanced atherosclerotic lesions of apoE–/– mice in vivo. These data show that enhanced macrophage proteolytic activity can induce acute plaque disruption and highlight MMP-9 as a potential therapeutic target for stabilizing rupture-prone plaques.

Authors

Peter J. Gough, Ivan G. Gomez, Paul T. Wille, Elaine W. Raines

×

Figure 1

Design and validation of experimental approach.

Options: View larger image (or click on image) Download as PowerPoint
Design and validation of experimental approach.
(A) Schematic representa...
(A) Schematic representation of the HSC transplantation experimental design. Bone marrow cells were harvested from 6- to 8-week-old apoE–/– donor mice and were transduced with macrophage-specific retroviral vectors encoding HA epitope–tagged EGFP (CD68S-HA-EGFP) or MMP-9 (CD68S–MMP-9) (29). After transduction, cells were injected intravenously into 35- to 45-week-old recipient apoE–/– mice. Mice were sacrificed 12 weeks after transplant, and lesion characteristics in the brachiocephalic artery were analyzed. (B–E) Analysis of retroviral gene expression in preestablished atherosclerotic lesions. Immunohistochemistry of similar lesions from apoE–/– mice transplanted with HSCs transduced with CD68S-HA-EGFP (B and C) or CD68S–MMP-9 (D and E) retroviruses reveals comparable levels of macrophage staining with an antibody recognizing MAC-2 (B and D). Only a subset of macrophages in lesions from mice receiving CD68S-HA-EGFP–transduced HSCs show reactivity with an antibody against the HA epitope (C and E). Original magnification, ×10 (B–E).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts